Publication
Redox activation of JNK2 alpha 2 mediates thyroid hormone-stimulated proliferation of neonatal murine cardiomyocytes
Downloadable Content
- Persistent URL
- Last modified
- 05/20/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2019-11-27
- Publisher
- Nature Research (part of Springer Nature): Fully open access journals
- Publication Version
- Copyright Statement
- © 2019, The Author(s).
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 2045-2322
- Volume
- 9
- Issue
- 1
- Start Page
- 17731
- End Page
- 17731
- Grant/Funding Information
- This work was supported by grants from the Department of Medicine, Emory University; the Carlyle Fraser Heart Center; Emory University Hospital Midtown; the NIH (HL079040, HL127726, HL098481, T32HL007745, HL092141, HL093579, HL094373, and HL113452); the American Heart Association (13SDG16460006; 17GRNT33670975); the Fondation Leducq Transatlantic Network; the National Health and Medical Research Council, Australia (APP1074386); the R.T. Hall estate; and the Australian Research Council Stem Cells Australia, Special Initiative in Stem Cell Science grant (SR1101002).
- Supplemental Material (URL)
- Abstract
- Mitochondria-generated reactive oxygen species (mROS) are frequently associated with DNA damage and cell cycle arrest, but physiological increases in mROS serve to regulate specific cell functions. T3 is a major regulator of mROS, including hydrogen peroxide (H2O2). Here we show that exogenous thyroid hormone (T3) administration increases cardiomyocyte numbers in neonatal murine hearts. The mechanism involves signaling by mitochondria-generated H2O2 (mH2O2) acting via the redox sensor, peroxiredoxin-1, a thiol peroxidase with high reactivity towards H2O2 that activates c-Jun N-terminal kinase-2α2 (JNK2α2). JNK2α2, a relatively rare member of the JNK family of mitogen-activated protein kinases (MAPK), phosphorylates c-Jun, a component of the activator protein 1 (AP-1) early response transcription factor, resulting in enhanced insulin-like growth factor 1 (IGF-1) expression and activation of proliferative ERK1/2 signaling. This non-canonical mechanism of MAPK activation couples T3 actions on mitochondria to cell cycle activation. Although T3 is regarded as a maturation factor for cardiomyocytes, these studies identify a novel redox pathway that is permissive for T3-mediated cardiomyocyte proliferation—this because of the expression of a pro-proliferative JNK isoform that results in growth factor elaboration and ERK1/2 cell cycle activation.
- Author Notes
- Keywords
- Research Categories
- Health Sciences, Medicine and Surgery
- Biology, Cell
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - vdsmj.pdf | Primary Content | 2025-04-08 | Public | Download |